Who could benefit most.

An estimated 8.5 to 10 million Medicaid enrollees are living with conditions indicated for psychedelic-assisted therapy — PTSD, treatment-resistant depression, anxiety disorders, and substance use disorders — and are not improving on available treatments. Medicaid enrollees are also six times more likely to live below the poverty line than the general population, three times more likely to have experienced four or more adverse childhood events, and significantly more likely to be people of color or unable to work due to disability.

The two charts below — drawn directly from PMHA Alliance’s Access 2030 plan — show who could benefit most: first by condition, then by demographic profile.